‘Adverse event’ won’t affect vaccine rollout plan: Govt
Sushmi.Dey New Delhi: The initial causality assessment of the adverse event in the “Covishield” vaccine trials being conducted by Pune-based Serum Institute of India (SII)...
Serum Institute of India
Pune SII: Will apply for emergency licence for vaccine use within two weeks
PUNE: Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said they were in the process of applying for an emergency use licence (for...
COVID vaccine will be distributed initially in India; amazed at how much PM Modi knew: Adar Poonawalla – The Economic Times Video
COVID-19 vaccine will be distributed initially in India, informed Chief executive officer (CEO) of Serum Institute of India, Adar Poonawalla on November 28. PM Modi...
Centre may purchase 300-400 million Covishield doses by July 2021: Adar Poonawalla
After Prime Minister Narendra Modi visited the company’s pandemic level facility in Pune, Serum Institute of India‘s (SII), Chief Executive Officer (CEO) Adar Poonawalla on...
Serum Institute in talks with Indian govt on pricing, distribution of Covid vaccines
MUMBAI: Serum Institute of India (SII), the world’s largest vaccine producer, is in active discussions with the Indian government on pricing and distribution of potential...
Covid-19: Prime Minister Modi to visit Serum Institute of India in Pune on November 28
PUNE: Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the...
Oxford vaccine ‘70% effective’, may get India nod by year-end
Rupali.Mukherjee Mumbai: Armed with interim findings of the AstraZeneca-Oxford Covid-19 vaccine trials — which showed 70% effectiveness in preventing people from getting infected — Pune-based...
astrazeneca: Serum Institute says they’ve produced 40 million doses of the AstraZeneca COVID-19 vaccine
BENGALURU: Serum Institute of India, the world’s largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca‘s potential COVID-19 vaccine, and...
Serum Institute-ICMR finish enrollment of participants for phase 3 trial of Covid-19 vaccine
Mumbai: Serum Institute of India (SII) and the Indian Council of Medical Research (ICMR), have completed the enrollment of phase 3 clinical trials for their...
Zydus Cadila to test ZyCoV-D on 30,000 patients in Phase-3 trials
New Delhi: Zydus Cadila is expected to test its Covid vaccine candidate, ZyCoV-D, on about 30,000 people in the Phase-3 trials that it plans to...